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Without Leading to Increased Thromboembolic Complications?Heparin is routinely administered immediately before ca-
rotid clamping to achieve systemic anti-coagulation during
carotid endarterectomy (CEA) to help avoid thromboem-
bolic complications. However, despite the large volume of
literature dedicated to CEA, there remains some contro-
versy regarding the safety of subsequent reversal of the
heparin using protamine sulphate (PS). The routine admin-
istration of protamine varies within studies, but ranges from
as low as 26% to as high as 46%.1,2
The decision process for the use of PS is based on the
perceived risk of postoperative bleeding complications,
which are generally not life-threatening, versus the risk of
potentially fatal cerebral thrombotic complications.
The early evidence in the literature certainly suggested a
signiﬁcant association between PS use and increased stroke
rates.3 However, more recent data contradict earlier reports
and suggest a reduction in bleeding complications without
any excess of strokes.2,1
The individual studies looking at this question may be
criticised from a number of perspectives, including the
retrospective design, single institution studies with small
numbers, and low statistical power.3 The low event rates in
many of the studies allied with relatively small numbers
make it quite possible that both type I and type II errors
may prejudice the ﬁndings linking rates of ischaemic events
with the use of PS.
The advent of a growing number of antiplatelet agents
and regimens in use nowadays further complicates inter-
pretation of previous data. A 2008 survey of European
vascular surgeons found consensus as to the agents used
but a broad variation in dosing, dual use, and timings of
commencement and cessation.4
Similarly, difﬁculties arise in trying to explicate the as-
sociation between PS usage and thrombotic complications
when one considers the inter-study variables of ﬁxed dosing
or per body weight heparin dosing, and also the employ-
ment or not of heparin activity monitoring via activated
clotting times (ACT) and subsequent maintenance dosing of
heparin to maintain a desirable ACT range.
What can be said without doubt is that postoperative
bleeding or thromboembolic complications are multifacto-
rial events and that the risks may be ameliorated using1078-5884/ 2015 European Society for Vascular Surgery. Published by
Elsevier Ltd. All rights reserved.
http://dx.doi.org/10.1016/j.ejvs.2015.09.001tools available to us all in our surgical armamentarium.
Meticulous surgical technique that minimises manipulation
of the artery during dissection and achieves a smooth
margin at the endarterectomy site should be practised by
all. Similarly, haemostasis should be maintained throughout
the procedure, and close communication with the anaes-
thetic team also should be maintained throughout the
procedure.
Although no clinical guidelines exist, current evidence
suggests it would not be difﬁcult to recommend the routine
reversal of heparin with PS post CEA; however, it is of
paramount importance that the individual surgeon is
comfortable with his or her own practice and technique and
that audited outcomes are in keeping with international
best standards. The best available data, although not level I
evidence, are certainly robust enough to suggest that
routine reversal of heparin with PS in patients undergoing
CEA may reduce bleeding complications without leading to
increased thromboembolic complications.
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